RxDoctor Payments Data

James Costabile, PA

Medical · Solomons, MDNPI 1720362254

Payments from drug & device makers

$768in general payments, 2019–2025

Across 40 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$131
  • Novo Nordisk$126
  • AbbVie$106
  • AstraZeneca$102
  • Pfizer$87
  • GSK$46
  • plus $169 from 8 others

What the payments were for

  • Food & beverage$75298%
  • Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$768 in reported general payments places this provider in the 60th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$53,754
Medicare patients
215
Services billed
905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$105,254
OzempicSemaglutide12$23,391
EliquisApixaban18$13,748
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,583
Breo ElliptaFluticasone/Vilanterol13$5,496
MovantikNaloxegol Oxalate11$5,400
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$4,751
Celecoxib14$2,311
Albuterol Sulfate HfaAlbuterol Sulfate62$1,434
Atorvastatin Calcium120$1,090
Losartan Potassium98$967
Ezetimibe29$879
Levothyroxine Sodium58$832
Omeprazole51$754
Metoprolol Succinate40$747

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$126$23,39112 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$46$18,83038 claims
PfizerEliquis$87$13,74818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 543 medical providers in Maryland.

Other medical in Solomons

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →